EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Hepatitis B Virus Nucleocapsid Assembly

Xupeng Hong, William M Schneider, Charles M Rice

Journal of Molecular Biology · 2025

DOI: 10.1016/j.jmb.2025.169182 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Molecular Biology, 2025. Verfasst von Xupeng Hong und 2 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA. Electronic address: xhong@rockefeller.edu. Hauptthemen laut MEDLINE: Hepatitis B virus, Nucleocapsid, Virus Assembly. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 220 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, GlaxoSmithKline, National Institutes of Health National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis B virus (HBV), the prototypical member of the Hepadnaviridae family, is a DNA virus that replicates its genome through reverse transcription of a pregenomic RNA (pgRNA) precursor. The selective packaging of pgRNA and viral polymerase (Pol) into assembling capsids formed by the viral core protein-a process known as nucleocapsid assembly-is an essential step in the HBV lifecycle. Advances in cellular and cell-free systems have provided significant insights into the mechanisms underlying capsid assembly, Pol binding to pgRNA, Pol-pgRNA packaging, and initiation of genome replication. However, the absence of a cell-free system capable of reconstituting selective HBV Pol-pgRNA packaging into fully assembled capsids leaves fundamental questions about nucleocapsid assembly unanswered. This review summarizes the current knowledge of HBV nucleocapsid assembly, focusing on the interplay between Pol-pgRNA interactions, capsid formation, and regulation by host factors. It also highlights the contribution of cellular and cell-free systems to these discoveries and underscores the need for new approaches that reconstitute the complete HBV nucleocapsid assembly process. With the growing interest in developing nucleocapsid assembly inhibitors, some of which are currently in clinical trials, targeting Pol-pgRNA interactions and nucleocapsid assembly represents a promising therapeutic strategy for curing chronic hepatitis B.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B virusNucleocapsidVirus AssemblyHumansRNA, ViralCapsidVirus ReplicationRNA

Stichwörter der Autor:innen

genome packaginghepatitis B virushost factornucleocapsid assemblyviral polymerase

Substanzen

RNA, ViralpgRNARNA

Autor:innen und Institutionen

  • Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA. Electronic address: xhong@rockefeller.edu.
  • Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.

Förderung

  • NIAID NIH HHS
  • GlaxoSmithKline
  • National Institutes of Health National Institute of Allergy and Infectious Diseases
  • Vir Biotechnology
  • National Institutes of Health
  • Rockefeller University
  • Stavros Niarchos Foundation

Zitieren

APA

Hong, X., Schneider, W. M., & Rice, C. M. (2025). Hepatitis B Virus Nucleocapsid Assembly. Journal of Molecular Biology. https://doi.org/10.1016/j.jmb.2025.169182

Vancouver

Hong X, Schneider WM, Rice CM. Hepatitis B Virus Nucleocapsid Assembly. Journal of Molecular Biology. 2025. doi:10.1016/j.jmb.2025.169182

BibTeX
@article{Hong2025,
  author = {Hong, Xupeng and Schneider, William M and Rice, Charles M},
  title = {Hepatitis B Virus Nucleocapsid Assembly},
  journal = {Journal of Molecular Biology},
  year = {2025},
  doi = {10.1016/j.jmb.2025.169182}
}
Kostenlos starten →